{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:26:05Z","timestamp":1792167965425,"version":"4.4.0"},"reference-count":141,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.bbr.2009.12.048","type":"journal-article","created":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T04:16:33Z","timestamp":1262837793000},"page":"564-573","source":"Crossref","is-referenced-by-count":504,"title":["The cholinergic system and Parkinson disease"],"prefix":"10.1016","volume":"221","author":[{"given":"Nicolaas I.","family":"Bohnen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Albin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2009.12.048_bib1","article-title":"The epidemiology of dementia associated with Parkinson disease","author":"Aarsland","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.bbr.2009.12.048_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/BF00230981","article-title":"Tonically discharging neurons of monkey striatum respond to preparatory and rewarding stimuli","volume":"84","author":"Apicella","year":"1991","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.bbr.2009.12.048_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00697388","article-title":"Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease","volume":"61","author":"Arendt","year":"1983","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.bbr.2009.12.048_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jnnp.65.2.155","article-title":"Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study","volume":"65","author":"Asahina","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1471-4159.1986.tb02858.x","article-title":"Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system","volume":"47","author":"Atack","year":"1986","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2009.12.048_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1471-4159.1992.tb09752.x","article-title":"Comparative alterations of nico-tinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases","volume":"58","author":"Aubert","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2009.12.048_bib7","first-page":"802","article-title":"The pathogenesis of Parkinson's disease: a new hypothesis","volume":"87","author":"Barbeau","year":"1962","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.bbr.2009.12.048_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/1999\/316598","article-title":"Induction of a transient dysexecutive syndrome in Parkinson's disease using a subclinical dose of scopolamine","volume":"11","author":"Bedard","year":"1998","journal-title":"Behav Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/brcg.1999.1083","article-title":"Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico-frontal syndrome","volume":"40","author":"Bedard","year":"1999","journal-title":"Brain Cogn"},{"key":"10.1016\/j.bbr.2009.12.048_bib10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0896-6273(02)00627-X","article-title":"A network representation of response probability in the striatum","volume":"33","author":"Blazquez","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2009.12.048_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jnnp.2006.100073","article-title":"Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia","volume":"78","author":"Bohnen","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00415-005-0971-0","article-title":"Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia","volume":"253","author":"Bohnen","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib13","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study","volume":"60","author":"Bohnen","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib14","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","article-title":"History of falls in Parkinson disease is associated with reduced cholinergic activity","volume":"73","author":"Bohnen","year":"2009","journal-title":"Neurology"},{"issue":"Suppl 2","key":"10.1016\/j.bbr.2009.12.048_bib15","first-page":"238P","article-title":"Ratings of activities of daily living are associated with cortical cholinergic but not with the degree of nigrostriatal dopaminergic activity in Parkinson disease","volume":"50","author":"Bohnen","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bbr.2009.12.048_bib16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/brain\/99.3.459","article-title":"Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies","volume":"99","author":"Bowen","year":"1976","journal-title":"Brain"},{"issue":"Suppl 3","key":"10.1016\/j.bbr.2009.12.048_bib17","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)","volume":"249","author":"Braak","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bbr.2009.12.048_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0022-510X(83)90045-X","article-title":"Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases","volume":"59","author":"Candy","year":"1983","journal-title":"J Neurol Sci"},{"issue":"Suppl 1","key":"10.1016\/j.bbr.2009.12.048_bib20","first-page":"S259","article-title":"Cholinergic augmentation in frequently fallings subjects with Parkinson's disease","volume":"24","author":"Chung","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2009.12.048_bib21","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.49.6.1570","article-title":"The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease","volume":"49","author":"Churchyard","year":"1997","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.bbr.2009.12.048_bib22","doi-asserted-by":"crossref","first-page":"I22","DOI":"10.1136\/jnnp.72.suppl_1.i22","article-title":"Medical management of Parkinson's disease","volume":"72","author":"Clarke","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0896-6273(92)90031-8","article-title":"The alpha 5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain","volume":"9","author":"Conroy","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2009.12.048_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2005.03.024","article-title":"Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease","volume":"30","author":"Cools","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2009.12.048_bib25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/sj.npp.1301153","article-title":"l-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease","volume":"32","author":"Cools","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.12.048_bib26","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/brain\/115.6.1701","article-title":"Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients","volume":"115","author":"Cooper","year":"1992","journal-title":"Brain"},{"issue":"II","key":"10.1016\/j.bbr.2009.12.048_bib27","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2009.12.048_bib28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.281.15.1401","article-title":"Cholinergic markers in elderly patients with early signs of Alzheimer disease","volume":"281","author":"Davis","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bbr.2009.12.048_bib29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/cne.903280304","article-title":"Cholinergic innervation of the human cerebellum","volume":"328","author":"de Lacalle","year":"1993","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.10069","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/neur.1995.0011","article-title":"Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria","volume":"4","author":"Doty","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.bbr.2009.12.048_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0361-9230(87)90129-8","article-title":"Presence of both odor identification and detection deficits in Alzheimer's disease","volume":"18","author":"Doty","year":"1987","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bbr.2009.12.048_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ana.410220108","article-title":"Cholinergic-dependent cognitive deficits in Parkinson's disease","volume":"22","author":"Dubois","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ana.410280202","article-title":"Cholinergic deficiency and frontal dysfunction in Parkinson's disease","volume":"28","author":"Dubois","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archneur.1967.00470260014002","article-title":"Cholinergic-anticholinergic antagonism in parkinsonism","volume":"17","author":"Duvoisin","year":"1967","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib36","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","article-title":"Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography","volume":"79","author":"Edison","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1474-8673.2006.00368.x","article-title":"Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function","volume":"26","author":"Eglen","year":"2006","journal-title":"Auton Autacoid Pharmacol"},{"key":"10.1016\/j.bbr.2009.12.048_bib38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0165-0173(82)90011-X","article-title":"The organization and some projections of cholinergic neurons of the mammalian forebrain","volume":"4","author":"Fibiger","year":"1982","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.bbr.2009.12.048_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0026-895X(25)08832-7","article-title":"A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment","volume":"41","author":"Flores","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bbr.2009.12.048_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1523\/JNEUROSCI.05-02-00421.1985","article-title":"Quantitative in vivo receptor binding I. Theory and application to the muscarinic cholinergic receptor","volume":"5","author":"Frey","year":"1985","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2009.12.048_bib41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.20688","article-title":"Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease","volume":"59","author":"Fujita","year":"2006","journal-title":"Ann Neurol"},{"issue":"Pt 5","key":"10.1016\/j.bbr.2009.12.048_bib42","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1093\/brain\/114.5.2253","article-title":"Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson's disease","volume":"114","author":"Gai","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2009.12.048_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0306-4522(89)90399-0","article-title":"Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study","volume":"33","author":"Geula","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2009.12.048_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cercor\/6.2.165","article-title":"Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease","volume":"6","author":"Geula","year":"1996","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.bbr.2009.12.048_bib45","series-title":"Alzheimer disease","first-page":"69","article-title":"Cholinergic systems in Alzheimer's disease","author":"Geula","year":"1999"},{"key":"10.1016\/j.bbr.2009.12.048_bib46","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1192\/bjp.154.5.596","article-title":"Dementia and Parkinson's disease","volume":"154","author":"Gibb","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1212\/01.WNL.0000073624.13436.32","article-title":"Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA","volume":"61","author":"Gilman","year":"2003","journal-title":"Neurology"},{"issue":"Suppl 3","key":"10.1016\/j.bbr.2009.12.048_bib48","first-page":"A145","article-title":"Cerebral cholinergic deficits in Parkinsonian syndromes","volume":"72","author":"Gilman","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.12.048_bib49","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1054-3589(08)60846-7","article-title":"The cortical dopamine system: role in memory and cognition","volume":"42","author":"Goldman-Rakic","year":"1998","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.bbr.2009.12.048_bib50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/brain\/111.2.299","article-title":"\u2019Frontal\u2019 cognitive function in patients with Parkinson's disease \u2018on\u2019 and \u2018off\u2019 levodopa","volume":"111","author":"Gotham","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2009.12.048_bib51","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1212\/01.WNL.0000031426.21683.E2","article-title":"Cognitive impairments in advanced PD without dementia","volume":"59","author":"Green","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.12.048_bib52","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.parkreldis.2008.12.005","article-title":"Prevalence of smell loss in Parkinson's disease\u2014a multicenter study","volume":"15","author":"Haehner","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.bbr.2009.12.048_bib53","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","article-title":"Parkinson's disease: the dual hit theory revisited","volume":"1170","author":"Hawkes","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bbr.2009.12.048_bib54","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1749-6632.1998.tb10631.x","article-title":"Olfactory evoked responses and identification tests in neurological disease","volume":"855","author":"Hawkes","year":"1998","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bbr.2009.12.048_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cne.903250107","article-title":"Cholinergic innervation of the human thalamus: dual origin and differential nuclear distribution","volume":"325","author":"Heckers","year":"1992","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0197-4580(92)90072-6","article-title":"Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease","volume":"13","author":"Heckers","year":"1992","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bbr.2009.12.048_bib57","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","article-title":"Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways","volume":"65","author":"Hilker","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.12.048_bib58","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/mds.22056","article-title":"PET study of brain acetylcholinesterase in cerebellar degenerative disorders","volume":"23","author":"Hirano","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2009.12.048_bib59","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1073\/pnas.84.16.5976","article-title":"Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy","volume":"84","author":"Hirsch","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2009.12.048_bib60","first-page":"19","article-title":"Biochemical pathophysiology of Parkinson's disease","volume":"45","author":"Hornykiewicz","year":"1987","journal-title":"Adv Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib61","first-page":"21","article-title":"Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AChE) in vivo","author":"Irie","year":"1994","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.bbr.2009.12.048_bib62","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp.51.4.540","article-title":"The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease","volume":"51","author":"Jellinger","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib63","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0894-4105.17.3.482","article-title":"Functional anatomy of human odor sensation, discrimination, and identification in health and aging","volume":"17","author":"Kareken","year":"2003","journal-title":"Neuropsychology"},{"key":"10.1016\/j.bbr.2009.12.048_bib64","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/jcbfm.2009.74","article-title":"Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease","volume":"29","author":"Kas","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.bbr.2009.12.048_bib65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<123::AID-SYN5>3.0.CO;2-F","article-title":"In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdinyl-4-propionate ([11C]PMP)","volume":"22","author":"Kilbourn","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2009.12.048_bib66","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1152\/jn.1990.63.6.1277","article-title":"Behaviorally contingent property of movement-related activity of the primate putamen","volume":"63","author":"Kimura","year":"1990","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.bbr.2009.12.048_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(78)91047-8","article-title":"Regional distribution of muscarinic cholinergic receptors in rat brain","volume":"154","author":"Kobayashi","year":"1978","journal-title":"Brain Res"},{"issue":"Suppl 3","key":"10.1016\/j.bbr.2009.12.048_bib68","doi-asserted-by":"crossref","first-page":"III\/1","DOI":"10.1007\/PL00022916","article-title":"Dementia in Parkinson's disease","volume":"248","author":"Korczyn","year":"2001","journal-title":"J Neurol"},{"issue":"Suppl 3","key":"10.1016\/j.bbr.2009.12.048_bib69","first-page":"A146","article-title":"Parkinson and Alzheimer-selective hyposmia measures have different neurochemical substrates in patients with Parkinson's disease","volume":"72","author":"Kotagal","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.12.048_bib70","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.410400309","article-title":"In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease","volume":"40","author":"Kuhl","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib71","first-page":"405","article-title":"In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM","volume":"35","author":"Kuhl","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bbr.2009.12.048_bib72","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1471-4159.1993.tb05838.x","article-title":"Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease","volume":"60","author":"Lange","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2009.12.048_bib73","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20834","article-title":"The Parkinson's complex: parkinsonism is just the tip of the iceberg","volume":"59","author":"Langston","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib74","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.neubiorev.2007.01.004","article-title":"A conductor hidden in the orchestra? Role of the habenular complex in monoamine transmission and cognition","volume":"31","author":"Lecourtier","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2009.12.048_bib75","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3349\/ymj.2000.41.2.167","article-title":"The pedunculopontine nucleus: its role in the genesis of movement disorders","volume":"41","author":"Lee","year":"2000","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.bbr.2009.12.048_bib76","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cne.903300103","article-title":"Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease","volume":"330","author":"Lehericy","year":"1993","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib77","first-page":"50","article-title":"Zur pathologischen Anatomie der Paralysis agitans","volume":"50","author":"Lewy","year":"1913","journal-title":"Dtsch Ztschr Nervenheilkunde"},{"key":"10.1016\/j.bbr.2009.12.048_bib78","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jns.2006.05.022","article-title":"Are dementia and depression in Parkinson's disease related?","volume":"248","author":"Lieberman","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.bbr.2009.12.048_bib79","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.410060409","article-title":"Dementia in Parkinson's disease","volume":"6","author":"Lieberman","year":"1979","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib80","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002093-199040300-00002","article-title":"Alzheimer disease and the dementia of Parkinson disease: Comparative investigations","volume":"4","author":"Mahler","year":"1990","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.bbr.2009.12.048_bib81","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archneur.1995.00540310069018","article-title":"The frequency and associated risk factors for dementia in patients with Parkinson's disease","volume":"52","author":"Marder","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib82","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cne.902780209","article-title":"Distribution of muscarinic receptor subtypes within architectonic subregions of the primate cerebral cortex","volume":"278","author":"Mash","year":"1988","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib83","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s004010100372","article-title":"Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment","volume":"102","author":"Mattila","year":"2001","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.bbr.2009.12.048_bib84","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004010050843","article-title":"Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease","volume":"95","author":"Mattila","year":"1998","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.bbr.2009.12.048_bib85","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.31.6.645","article-title":"Depression, intellectual impairment, and Parkinson's disease","volume":"31","author":"Mayeux","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.12.048_bib86","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/archneur.1988.00520270034017","article-title":"An estimate of the prevalence of dementia in idiopathic Parkinson's disease","volume":"45","author":"Mayeux","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib87","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.12.048_bib88","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneur.55.1.84","article-title":"Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer's and Parkinson's diseases","volume":"55","author":"Mesholam","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib89","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1101\/lm.69204","article-title":"The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?","volume":"11","author":"Mesulam","year":"2004","journal-title":"Learn Mem"},{"key":"10.1016\/j.bbr.2009.12.048_bib90","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cne.903230209","article-title":"Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus","volume":"323","author":"Mesulam","year":"1992","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib91","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cne.902750205","article-title":"Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase","volume":"275","author":"Mesulam","year":"1988","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib92","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0006-8993(92)90543-I","article-title":"Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex","volume":"577","author":"Mesulam","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2009.12.048_bib93","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/archgenpsychiatry.2009.106","article-title":"Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease","volume":"66","author":"Meyer","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib94","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cne.10122","article-title":"Loss of basal forebrain P75 (NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease","volume":"443","author":"Mufson","year":"2002","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib95","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1054\/jocn.2001.1071","article-title":"Olfactory function in Parkinsonian syndromes","volume":"9","author":"Muller","year":"2002","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.bbr.2009.12.048_bib96","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0197-4580(90)90014-Q","article-title":"Olfactory thresholds are associated with degree of dementia in Alzheimer's disease","volume":"11","author":"Murphy","year":"1990","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bbr.2009.12.048_bib97","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410150503","article-title":"Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease","volume":"5","author":"Nakano","year":"1984","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"10.1016\/j.bbr.2009.12.048_bib98","first-page":"95P","article-title":"In vivo measurement of acetylcholinesterase activity of the brains of Alzheimer's disease and Parkinson's disease","volume":"39","author":"Namba","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bbr.2009.12.048_bib99","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/brain\/123.9.1767","article-title":"The pedunculopontine nucleus and Parkinson's disease","volume":"123","author":"Pahapill","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2009.12.048_bib100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/brain\/117.2.235","article-title":"The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology","volume":"117","author":"Papp","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2009.12.048_bib101","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-0082(99)00045-3","article-title":"Neuronal nicotinic receptors in the human brain","volume":"61","author":"Paterson","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bbr.2009.12.048_bib102","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jnnp.48.5.413","article-title":"Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease","volume":"48","author":"Perry","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib103","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00002093-199307020-00002","article-title":"Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease","volume":"7","author":"Perry","year":"1993","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.bbr.2009.12.048_bib104","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/brcg.1995.1255","article-title":"Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness","volume":"28","author":"Perry","year":"1995","journal-title":"Brain Cogn"},{"key":"10.1016\/j.bbr.2009.12.048_bib105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(77)91780-9","article-title":"Necropsy evidence of central cholinergic deficits in senile dementia","author":"Perry","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2009.12.048_bib106","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.npp.1300302","article-title":"Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380","volume":"29","author":"Pimlott","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2009.12.048_bib107","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0278-2626(82)90007-0","article-title":"Dementia in Parkinson disease: a neuropsychological analysis","volume":"1","author":"Pirozzolo","year":"1982","journal-title":"Brain Cogn"},{"key":"10.1016\/j.bbr.2009.12.048_bib108","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.bbr.2009.12.048_bib109","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/mds.870130304","article-title":"Clinical assessment of olfactory dysfunction in Parkinson's disease","volume":"13","author":"Potagas","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2009.12.048_bib110","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1152\/jn.1996.76.3.2083","article-title":"Neuronal synchronization of tonically active neurons in the striatum of normal and parkinsonian primates","volume":"76","author":"Raz","year":"1996","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.bbr.2009.12.048_bib111","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ana.410170210","article-title":"The nucleus basalis of Meynert in neurological disease: a quantitative morphological study","volume":"17","author":"Rogers","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib112","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-8993(82)90615-1","article-title":"Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia","volume":"232","author":"Ruberg","year":"1982","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2009.12.048_bib113","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-8993(86)91401-0","article-title":"Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease","volume":"362","author":"Ruberg","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2009.12.048_bib114","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00005072-199705000-00006","article-title":"Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density","volume":"56","author":"Samuel","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib115","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/brain\/121.12.2249","article-title":"Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain","volume":"121","author":"Selden","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2009.12.048_bib116","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1176\/ajp.148.3.357","article-title":"The nature and course of olfactory deficits in Alzheimer's disease","volume":"148","author":"Serby","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib117","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","article-title":"Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET","volume":"73","author":"Shimada","year":"2009","journal-title":"Neurology"},{"issue":"Suppl 3","key":"10.1016\/j.bbr.2009.12.048_bib118","doi-asserted-by":"crossref","first-page":"iii30","DOI":"10.1007\/s00415-006-3006-6","article-title":"Neuroimaging of PD, PSP, CBD and MSA-PET and SPECT studies","volume":"253","author":"Shinotoh","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib119","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/1531-8249(199907)46:1<62::AID-ANA10>3.0.CO;2-P","article-title":"Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy","volume":"46","author":"Shinotoh","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib120","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF00406286","article-title":"Electron microscopy of cholinergic terminals and acetylcholinesterase-containing neurones in the hippocampal formation of the rat","volume":"69","author":"Shute","year":"1966","journal-title":"Z Zellforsch Mikrosk Anat"},{"key":"10.1016\/j.bbr.2009.12.048_bib121","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2009.02.006","article-title":"Regional differences in the severity of Lewy body pathology across the olfactory cortex","volume":"453","author":"Silveira-Moriyama","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2009.12.048_bib122","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy: a heterogeneous degeneration involving the brainstem, basal ganglia, and cerebellum, with vertical gaze and pseudobulbar palsy","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2008.09.022","article-title":"Akinesia, motor oscillations and the pedunculopontine nucleus in rats and men","volume":"215","author":"Stein","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib124","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1212\/WNL.58.7.1013","article-title":"Cholinergic vesicular transporters in progressive supranuclear palsy","volume":"58","author":"Suzuki","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.12.048_bib125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ana.20533","article-title":"A 10-item smell identification scale related to risk for Alzheimer's disease","volume":"58","author":"Tabert","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib126","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0404.1984.tb00798.x","article-title":"The basal nucleus of Meynert in idiopathic Parkinson's disease","volume":"70","author":"Tagliavini","year":"1984","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.bbr.2009.12.048_bib127","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/jnnp.2008.147629","article-title":"Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype","volume":"79","author":"Taylor","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib128","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1212\/WNL.55.9.1278","article-title":"The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease","volume":"55","author":"Tiraboschi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.12.048_bib129","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.59.10.946","article-title":"Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease","volume":"59","author":"Tiraboschi","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/WNL.54.2.407","article-title":"Cholinergic dysfunction in diseases with Lewy bodies","volume":"54","author":"Tiraboschi","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.12.048_bib131","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1001\/archneur.1995.00540360042014","article-title":"Neuropsychological impairment in Parkinson's disease with and without depression","volume":"52","author":"Tr\u00f6ster","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib132","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1073\/pnas.93.8.3547","article-title":"Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles","volume":"93","author":"Weihe","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2009.12.048_bib133","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/mds.20555","article-title":"Antidepressant studies in Parkinson's disease: a review and meta-analysis","volume":"20","author":"Weintraub","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2009.12.048_bib134","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410130304","article-title":"Basal forebrain neurons in the dementia of Parkinson disease","volume":"13","author":"Whitehouse","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib135","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1212\/WNL.38.5.720","article-title":"Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study","volume":"38","author":"Whitehouse","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2009.12.048_bib136","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer's disease: evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbr.2009.12.048_bib137","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","article-title":"The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort","volume":"132","author":"Williams-Gray","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2009.12.048_bib138","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.2006.099721","article-title":"The relationship between cerebral Alzheimer's disease pathology and odour identification in old age","volume":"78","author":"Wilson","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2009.12.048_bib139","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1567205043331992","article-title":"Alzheimer's disease: interactions between cholinergic functions and beta-amyloid","volume":"1","author":"Yan","year":"2004","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bbr.2009.12.048_bib140","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ageing\/afi190","article-title":"A systematic review of prevalence and incidence studies of dementia with Lewy bodies","volume":"34","author":"Zaccai","year":"2005","journal-title":"Age Ageing"},{"key":"10.1016\/j.bbr.2009.12.048_bib141","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ana.410260106","article-title":"The pedunculopontine nucleus in Parkinson's disease","volume":"26","author":"Zweig","year":"1989","journal-title":"Ann Neurol"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432810000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432810000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T10:15:05Z","timestamp":1739700905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432810000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0166432810000161"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2009.12.048","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}